{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:13:58Z","timestamp":1790828038212,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":67,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811072291","type":"print"},{"value":"9789811072307","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-10-7230-7_17","type":"book-chapter","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T06:29:29Z","timestamp":1528784969000},"page":"377-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["EBV-Encoded Latent Genes"],"prefix":"10.1007","author":[{"given":"Teru","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ijc.24223","volume":"124","author":"GW Bornkamm","year":"2009","unstructured":"Bornkamm GW (2009) Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Int J Cancer 124:1745\u20131755. https:\/\/doi.org\/10.1002\/ijc.24223","journal-title":"Int J Cancer"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1073\/pnas.100119497","volume":"97","author":"ED Cahir-McFarland","year":"2000","unstructured":"Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci U S A 97:6055\u20136060. https:\/\/doi.org\/10.1073\/pnas.100119497","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell RG, Wilson JB, Anderson SJ, Longnecker R (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9:405\u2013411","journal-title":"Immunity"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202\u2013209. https:\/\/doi.org\/10.1038\/nature13480","journal-title":"Nature"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.1073\/pnas.86.23.9558","volume":"86","author":"JI Cohen","year":"1989","unstructured":"Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A 86:9558\u20139562","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1006\/viro.2000.0344","volume":"272","author":"CW Dawson","year":"2000","unstructured":"Dawson CW, Eliopoulos AG, Blake SM, Barker R, Young LS (2000) Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology 272:204\u2013217. https:\/\/doi.org\/10.1006\/viro.2000.0344","journal-title":"Virology"},{"key":"17_CR7","first-page":"2982","volume":"63","author":"U Dirmeier","year":"2003","unstructured":"Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W (2003) Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus. Cancer Res 63:2982\u20132989","journal-title":"Cancer Res"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1128\/JVI.00785-08","volume":"82","author":"RH Edwards","year":"2008","unstructured":"Edwards RH, Marquitz AR, Raab-Traub N (2008) Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82:9094\u20139106. https:\/\/doi.org\/10.1128\/JVI.00785-08","journal-title":"J Virol"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-319-22822-8_4","volume":"390","author":"PJ Farrell","year":"2015","unstructured":"Farrell PJ (2015) Epstein-Barr virus strain variation. Curr Top Microbiol Immunol 390:45\u201369. https:\/\/doi.org\/10.1007\/978-3-319-22822-8_4","journal-title":"Curr Top Microbiol Immunol"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-319-22822-8_7","volume":"390","author":"R Feederle","year":"2015","unstructured":"Feederle R, Klinke O, Kutikhin A, Poirey R, Tsai MH, Delecluse HJ (2015) Epstein-Barr virus: from the detection of sequence polymorphisms to the recognition of viral types. Curr Top Microbiol Immunol 390:119\u2013148. https:\/\/doi.org\/10.1007\/978-3-319-22822-8_7","journal-title":"Curr Top Microbiol Immunol"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"11711","DOI":"10.1128\/JVI.01873-15","volume":"89","author":"G Gregorovic","year":"2015","unstructured":"Gregorovic G et al (2015) Epstein-Barr viruses (EBVs) deficient in EBV-encoded RNAs have higher levels of latent membrane protein 2 RNA expression in Lymphoblastoid cell lines and efficiently establish persistent infections in humanized mice. J Virol 89:11711\u201311714. https:\/\/doi.org\/10.1128\/JVI.01873-15","journal-title":"J Virol"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.1073\/pnas.90.18.8479","volume":"90","author":"S Henderson","year":"1993","unstructured":"Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90:8479\u20138483","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"10989","DOI":"10.1073\/pnas.1832776100","volume":"100","author":"S Humme","year":"2003","unstructured":"Humme S, Reisbach G, Feederle R, Delecluse HJ, Bousset K, Hammerschmidt W, Schepers A (2003) The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci U S A 100:10989\u201310994. https:\/\/doi.org\/10.1073\/pnas.1832776100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/JVI.72.5.4038-4048.1998","volume":"72","author":"RJ Johnson","year":"1998","unstructured":"Johnson RJ, Stack M, Hazlewood SA, Jones M, Blackmore CG, Hu LF, Rowe M (1998) The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. J Virol 72:4038\u20134048","journal-title":"J Virol"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/j.1460-2075.1984.tb01890.x","volume":"3","author":"MD Jones","year":"1984","unstructured":"Jones MD, Foster L, Sheedy T, Griffin BE (1984) The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO J 3:813\u2013821","journal-title":"EMBO J"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"24189","DOI":"10.1074\/jbc.M113.491167","volume":"288","author":"T Kanda","year":"2013","unstructured":"Kanda T et al (2013) Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance. J Biol Chem 288:24189\u201324199. https:\/\/doi.org\/10.1074\/jbc.M113.491167","journal-title":"J Biol Chem"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1128\/JVI.03189-14","volume":"89","author":"T Kanda","year":"2015","unstructured":"Kanda T, Miyata M, Kano M, Kondo S, Yoshizaki T, Iizasa H (2015) Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. J Virol 89:2684\u20132697. https:\/\/doi.org\/10.1128\/JVI.03189-14","journal-title":"J Virol"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1128\/JVI.00060-16","volume":"90","author":"T Kanda","year":"2016","unstructured":"Kanda T, Furuse Y, Oshitani H, Kiyono T (2016) Highly efficient CRISPR\/Cas9-mediated cloning and functional characterization of gastric cancer-derived Epstein-Barr virus strains. J Virol 90:4383\u20134393. https:\/\/doi.org\/10.1128\/JVI.00060-16","journal-title":"J Virol"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1038\/emm.2014.84","volume":"47","author":"MS Kang","year":"2015","unstructured":"Kang MS, Kieff E (2015) Epstein-Barr virus latent genes. Exp Mol Med 47:e131. https:\/\/doi.org\/10.1038\/emm.2014.84","journal-title":"Exp Mol Med"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","volume":"90","author":"KM Kaye","year":"1993","unstructured":"Kaye KM, Izumi KM, Kieff E (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90:9150\u20139154","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/nm758","volume":"8","author":"G Kelly","year":"2002","unstructured":"Kelly G, Bell A, Rickinson A (2002) Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 8:1098\u20131104. https:\/\/doi.org\/10.1038\/nm758","journal-title":"Nat Med"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"14935","DOI":"10.1073\/pnas.0509988103","volume":"103","author":"GL Kelly","year":"2006","unstructured":"Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB (2006) Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc Natl Acad Sci U S A 103:14935\u201314940. https:\/\/doi.org\/10.1073\/pnas.0509988103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"e1000341","DOI":"10.1371\/journal.ppat.1000341","volume":"5","author":"GL Kelly","year":"2009","unstructured":"Kelly GL et al (2009) An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp\/BHRF1 link. PLoS Pathog 5:e1000341. https:\/\/doi.org\/10.1371\/journal.ppat.1000341","journal-title":"PLoS Pathog"},{"key":"17_CR24","series-title":"Fields virology","first-page":"2603","volume-title":"Epstein-Barr virus and its replication","author":"E Kieff","year":"2007","unstructured":"Kieff E, Rickinson AB (2007) In: Knipe DM, Howley PM (eds) Epstein-Barr virus and its replication, Fields virology, vol 2, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2603\u20132654","edition":"5"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1099\/vir.0.045237-0","volume":"94","author":"DN Kim","year":"2013","unstructured":"Kim DN et al (2013) Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. J Gen Virol 94:497\u2013506. https:\/\/doi.org\/10.1099\/vir.0.045237-0","journal-title":"J Gen Virol"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014.02.002","volume":"26C","author":"O Klinke","year":"2014","unstructured":"Klinke O, Feederle R, Delecluse HJ (2014) Genetics of Epstein-Barr virus microRNAs. Semin Cancer Biol 26C:52\u201359. https:\/\/doi.org\/10.1016\/j.semcancer.2014.02.002","journal-title":"Semin Cancer Biol"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coviro.2014.04.003","volume":"7","author":"M Kuzembayeva","year":"2014","unstructured":"Kuzembayeva M, Hayes M, Sugden B (2014) Multiple functions are mediated by the miRNAs of Epstein-Barr virus. Curr Opin Virol 7:61\u201365. https:\/\/doi.org\/10.1016\/j.coviro.2014.04.003","journal-title":"Curr Opin Virol"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<83::AID-RMV262>3.0.CO;2-T","volume":"10","author":"ER Leight","year":"2000","unstructured":"Leight ER, Sugden B (2000) EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol 10:83\u2013100","journal-title":"Rev Med Virol"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"e1005344","DOI":"10.1371\/journal.ppat.1005344","volume":"11","author":"X Lin","year":"2015","unstructured":"Lin X et al (2015) The Epstein-Barr virus BART miRNA cluster of the M81 strain modulates multiple functions in primary B cells. PLoS Pathog 11:e1005344. https:\/\/doi.org\/10.1371\/journal.ppat.1005344","journal-title":"PLoS Pathog"},{"key":"17_CR30","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/JVI.67.4.2006-2013.1993","volume":"67","author":"R Longnecker","year":"1993","unstructured":"Longnecker R, Miller CL, Miao XQ, Tomkinson B, Kieff E (1993) The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. J Virol 67:2006\u20132013","journal-title":"J Virol"},{"key":"17_CR31","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1128\/JVI.65.12.6826-6837.1991","volume":"65","author":"JB Mannick","year":"1991","unstructured":"Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E (1991) The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65:6826\u20136837","journal-title":"J Virol"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1073\/pnas.1019599108","volume":"108","author":"S Maruo","year":"2011","unstructured":"Maruo S, Zhao B, Johannsen E, Kieff E, Zou J, Takada K (2011) Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci U S A 108:1919\u20131924. https:\/\/doi.org\/10.1073\/pnas.1019599108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.1073\/pnas.1514484112","volume":"112","author":"T Minamitani","year":"2015","unstructured":"Minamitani T et al (2015) Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A. Proc Natl Acad Sci U S A 112:11612\u201311617. https:\/\/doi.org\/10.1073\/pnas.1514484112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR34","doi-asserted-by":"publisher","unstructured":"Munz C (ed) (2015a) Epstein Barr virus volume 1 one herpes virus: many diseases, vol 390. Curr Top Microbiol. https:\/\/doi.org\/10.1007\/978-3-319-22822-8","DOI":"10.1007\/978-3-319-22822-8"},{"key":"17_CR35","doi-asserted-by":"publisher","unstructured":"Munz C (ed) (2015b) Epstein Barr virus volume 2 one herpes virus: many diseases, vol 390. Curr Top Microbiol. https:\/\/doi.org\/10.1007\/978-3-319-22834-1","DOI":"10.1007\/978-3-319-22834-1"},{"key":"17_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/rmv.363","volume":"12","author":"A Nanbo","year":"2002","unstructured":"Nanbo A, Takada K (2002) The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis. Rev Med Virol 12:321\u2013326. https:\/\/doi.org\/10.1002\/rmv.363","journal-title":"Rev Med Virol"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.cellsig.2004.03.001","volume":"16","author":"T Nitta","year":"2004","unstructured":"Nitta T, Chiba A, Yamamoto N, Yamaoka S (2004) Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma. Cell Signal 16:1071\u20131081. https:\/\/doi.org\/10.1016\/j.cellsig.2004.03.001","journal-title":"Cell Signal"},{"key":"17_CR38","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1182\/blood.V86.5.1893.bloodjournal8651893","volume":"86","author":"JJ Oudejans","year":"1995","unstructured":"Oudejans JJ et al (1995) BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood 86:1893\u20131902","journal-title":"Blood"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1128\/JVI.03614-14","volume":"89","author":"AL Palser","year":"2015","unstructured":"Palser AL et al (2015) Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection. J Virol 89:5222\u20135237. https:\/\/doi.org\/10.1128\/JVI.03614-14","journal-title":"J Virol"},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"e1000492","DOI":"10.1371\/journal.ppat.1000492","volume":"5","author":"K Paschos","year":"2009","unstructured":"Paschos K, Smith P, Anderton E, Middeldorp JM, White RE, Allday MJ (2009) Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog 5:e1000492. https:\/\/doi.org\/10.1371\/journal.ppat.1000492","journal-title":"PLoS Pathog"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1096781","volume":"304","author":"S Pfeffer","year":"2004","unstructured":"Pfeffer S et al (2004) Identification of virus-encoded microRNAs. Science 304:734\u2013736","journal-title":"Science"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"e1004561","DOI":"10.1371\/journal.ppat.1004561","volume":"11","author":"J Qiu","year":"2015","unstructured":"Qiu J, Smith P, Leahy L, Thorley-Lawson DA (2015) The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo. PLoS Pathog 11:e1004561. https:\/\/doi.org\/10.1371\/journal.ppat.1004561","journal-title":"PLoS Pathog"},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0092-8674(80)90173-7","volume":"22","author":"N Raab-Traub","year":"1980","unstructured":"Raab-Traub N, Dambaugh T, Kieff E (1980) DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 22:257\u2013267","journal-title":"Cell"},{"key":"17_CR44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/JVI.44.3.834-844.1982","volume":"44","author":"M Rabson","year":"1982","unstructured":"Rabson M, Gradoville L, Heston L, Miller G (1982) Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J Virol 44:834\u2013844","journal-title":"J Virol"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/JVI.03378-13","volume":"88","author":"N Renzette","year":"2014","unstructured":"Renzette N et al (2014) Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids. J Virol 88:3744\u20133755. https:\/\/doi.org\/10.1128\/JVI.03378-13","journal-title":"J Virol"},{"key":"17_CR46","series-title":"Fields virology","first-page":"2655","volume-title":"Epstein-Barr virus","author":"AB Rickinson","year":"2007","unstructured":"Rickinson AB, Kieff E (2007) In: Knipe M, Howley PM (eds) Epstein-Barr virus, Fields virology, vol 2, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2655\u20132700","edition":"5"},{"key":"17_CR47","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1128\/JVI.68.3.1449-1458.1994","volume":"68","author":"ES Robertson","year":"1994","unstructured":"Robertson ES, Tomkinson B, Kieff E (1994) An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. J Virol 68:1449\u20131458","journal-title":"J Virol"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semcancer.2009.07.004","volume":"19","author":"M Rowe","year":"2009","unstructured":"Rowe M, Kelly GL, Bell AI, Rickinson AB (2009) Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol 19:377\u2013388. https:\/\/doi.org\/10.1016\/j.semcancer.2009.07.004","journal-title":"Semin Cancer Biol"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"11487","DOI":"10.1128\/JVI.78.21.11487-11505.2004","volume":"78","author":"J Sears","year":"2004","unstructured":"Sears J, Ujihara M, Wong S, Ott C, Middeldorp J, Aiyar A (2004) The amino terminus of Epstein-Barr virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J Virol 78:11487\u201311505. https:\/\/doi.org\/10.1128\/JVI.78.21.11487-11505.2004","journal-title":"J Virol"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"e1001063","DOI":"10.1371\/journal.ppat.1001063","volume":"6","author":"E Seto","year":"2010","unstructured":"Seto E, Moosmann A, Gromminger S, Walz N, Grundhoff A, Hammerschmidt W (2010) Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6:e1001063","journal-title":"PLoS Pathog"},{"key":"17_CR51","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/JVI.73.4.2587-2595.1999","volume":"73","author":"K Shire","year":"1999","unstructured":"Shire K, Ceccarelli DF, Avolio-Hunter TM, Frappier L (1999) EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol 73:2587\u20132595","journal-title":"J Virol"},{"key":"17_CR52","doi-asserted-by":"publisher","first-page":"e1000951","DOI":"10.1371\/journal.ppat.1000951","volume":"6","author":"L Skalska","year":"2010","unstructured":"Skalska L, White RE, Franz M, Ruhmann M, Allday MJ (2010) Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog 6:e1000951. https:\/\/doi.org\/10.1371\/journal.ppat.1000951","journal-title":"PLoS Pathog"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1073\/pnas.88.4.1546","volume":"88","author":"S Swaminathan","year":"1991","unstructured":"Swaminathan S, Tomkinson B, Kieff E (1991) Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci U S A 88:1546\u20131550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR54","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nrmicro2015","volume":"6","author":"DA Thorley-Lawson","year":"2008","unstructured":"Thorley-Lawson DA, Allday MJ (2008) The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 6:913\u2013924. https:\/\/doi.org\/10.1038\/nrmicro2015","journal-title":"Nat Rev Microbiol"},{"key":"17_CR55","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JVI.66.5.2893-2903.1992","volume":"66","author":"B Tomkinson","year":"1992","unstructured":"Tomkinson B, Kieff E (1992) Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J Virol 66:2893\u20132903","journal-title":"J Virol"},{"key":"17_CR56","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.67.4.2014-2025.1993","volume":"67","author":"B Tomkinson","year":"1993","unstructured":"Tomkinson B, Robertson E, Kieff E (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67:2014\u20132025","journal-title":"J Virol"},{"key":"17_CR57","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.celrep.2013.09.012","volume":"5","author":"MH Tsai","year":"2013","unstructured":"Tsai MH et al (2013) Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep 5:458\u2013470. https:\/\/doi.org\/10.1016\/j.celrep.2013.09.012","journal-title":"Cell Rep"},{"key":"17_CR58","doi-asserted-by":"publisher","first-page":"E3473","DOI":"10.1073\/pnas.1202637109","volume":"109","author":"CM Tsang","year":"2012","unstructured":"Tsang CM et al (2012) Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proc Natl Acad Sci U S A 109:E3473\u2013E3482. https:\/\/doi.org\/10.1073\/pnas.1202637109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.4448","volume":"235","author":"SW Tsao","year":"2015","unstructured":"Tsao SW, Tsang CM, To KF, Lo KW (2015) The role of Epstein-Barr virus in epithelial malignancies. J Pathol 235:323\u2013333. https:\/\/doi.org\/10.1002\/path.4448","journal-title":"J Pathol"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1128\/JVI.01000-14","volume":"88","author":"S Tzellos","year":"2014","unstructured":"Tzellos S et al (2014) A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2. J Virol 88:8743\u20138753. https:\/\/doi.org\/10.1128\/JVI.01000-14","journal-title":"J Virol"},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1128\/JVI.77.11.6546-6550.2003","volume":"77","author":"DM Walling","year":"2003","unstructured":"Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD (2003) Multiple Epstein-Barr virus infections in healthy individuals. J Virol 77:6546\u20136550","journal-title":"J Virol"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","volume":"43","author":"D Wang","year":"1985","unstructured":"Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831\u2013840","journal-title":"Cell"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1128\/JVI.01616-09","volume":"84","author":"A Watanabe","year":"2010","unstructured":"Watanabe A, Maruo S, Ito T, Ito M, Katsumura KR, Takada K (2010) Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. J Virol 84:2893\u20132901. https:\/\/doi.org\/10.1128\/JVI.01616-09","journal-title":"J Virol"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1172\/JCI58092","volume":"122","author":"RE White","year":"2012","unstructured":"White RE et al (2012) EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest 122:1487\u20131502. https:\/\/doi.org\/10.1172\/JCI58092","journal-title":"J Clin Invest"},{"key":"17_CR65","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1128\/JVI.79.7.4298-4307.2005","volume":"79","author":"M Yajima","year":"2005","unstructured":"Yajima M, Kanda T, Takada K (2005) Critical role of Epstein-Barr virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J Virol 79:4298\u20134307. https:\/\/doi.org\/10.1128\/JVI.79.7.4298-4307.2005","journal-title":"J Virol"},{"key":"17_CR66","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757\u2013768. https:\/\/doi.org\/10.1038\/nrc1452","journal-title":"Nat Rev Cancer"},{"key":"17_CR67","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG (2016) Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer 16:789\u2013802. https:\/\/doi.org\/10.1038\/nrc.2016.92","journal-title":"Nat Rev Cancer"}],"container-title":["Advances in Experimental Medicine and Biology","Human Herpesviruses"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-7230-7_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T06:07:10Z","timestamp":1604383630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-7230-7_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811072291","9789811072307"],"references-count":67,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-7230-7_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}